Somatostatin and Dopamine-Somatostatin Multiple Ligands Directed towards Somatostatin and Dopamine Receptors in Pituitary Adenomas

Publisher： Karger

E-ISSN： 1423-0194|83|3-4|258-263

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.83, Iss.3-4, 2006-10, pp. : 258-263

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Medical Treatment of Acromegaly with Dopamine Agonists or Somatostatin Analogs

By  

Neuroendocrinology, Vol. 103, Iss. 1, 2016-0 ,pp. : 50-58

Karger

Access to resources Recommend Favorite

Somatostatin Receptor Expression in GH-Secreting Pituitary Adenomas Treated with Long-Acting Somatostatin Analogues in Combination with Pegvisomant

By  

Neuroendocrinology, Vol. 105, Iss. 1, 2016-07 ,pp. : 44-53

Karger

Access to resources Recommend Favorite

Expression of Somatostatin and Dopamine 2 Receptors in Neuroendocrine Tumours and the Potential Role for New Biotherapies

By  

Neuroendocrinology, Vol. 89, Iss. 3, 2009-03 ,pp. : 308-314

Karger

Access to resources Recommend Favorite

Expression of Somatostatin Receptors 1-5 and Dopamine Receptor 2 in Lung Carcinoids: Implications for a Therapeutic Role

By  

Neuroendocrinology, Vol. 101, Iss. 3, 2015-02 ,pp. : 211-222

Karger

Access to resources Recommend Favorite

Impact of gsp Oncogene on the mRNA Content for Somatostatin and Dopamine Receptors in Human Somatotropinomas

By  

Neuroendocrinology, Vol. 93, Iss. 1, 2010-11 ,pp. : 40-47

Karger

Access to resources Recommend Favorite